European Society for Medical Oncology (ESMO) Advanced Course on Early Drug Development 2025: Hong Kong SAR
OVERVIEW
European Society for Medical Oncology (ESMO) Advanced Course on Early Drug Development 2025 is organized by European Society for Medical Oncology (ESMO) and will be held from Jul 17 - 18, 2025 at Hong Kong, Hong Kong, China.
Learning Objectives:
- To foster, educate and mentor the next generation of Phase I/Early Drug Development Programmes in Oncology centres from both the established and emerging economies in the Asia-Pacific region
- To understand the fundamentals to establishing and running a successful Phase I/Early Drug Development Programme: from an in-depth understanding of trial selection to patient coordination, to running a programme, to effectively engaging with sponsors and fellow PIs, regional and international engagement, regulatory processes
- To bridge the gap between the key stakeholders in the drug development process in the Asia-Pacific region: investigators, sponsors (Pharma and Biotech), Contract Research Organization (CRO), regulatory bodies
KEY DATES
17 Jul, 2025
Event Start Date
18 Jul, 2025
Event End Date
ACCREDITATION & CREDITS
Accreditation
The programme of this event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology.
TARGET AUDIENCE
PharmacistMedical OncologistsSPECIALITIES
PharmacologyMedical OncologySUGGESTED HOTELS
CONFERENCE VENUE
TBDRELATED CONFERENCES & LIVE WEBINARS
Quick Links